West Nile Virus: FDA Clears PanBio Test, Canada Okays Roche Blood Screen
This article was originally published in The Gray Sheet
Executive Summary
The de novo 510(k) route pursued by PanBio for its Capture West Nile virus clinical lab test could set a precedent for expedited approvals of diagnostics to detect emerging diseases